GB0823445D0 - Biomarker - Google Patents

Biomarker

Info

Publication number
GB0823445D0
GB0823445D0 GBGB0823445.2A GB0823445A GB0823445D0 GB 0823445 D0 GB0823445 D0 GB 0823445D0 GB 0823445 A GB0823445 A GB 0823445A GB 0823445 D0 GB0823445 D0 GB 0823445D0
Authority
GB
United Kingdom
Prior art keywords
biomarker
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0823445.2A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Surrey
Original Assignee
University of Surrey
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Surrey filed Critical University of Surrey
Priority to GBGB0823445.2A priority Critical patent/GB0823445D0/en
Publication of GB0823445D0 publication Critical patent/GB0823445D0/en
Priority to JP2011541583A priority patent/JP5947040B2/ja
Priority to PCT/GB2009/002926 priority patent/WO2010073001A1/en
Priority to EP09805934.8A priority patent/EP2382327B1/en
Priority to RU2011130795/10A priority patent/RU2573925C2/ru
Priority to BRPI0923525-6A priority patent/BRPI0923525A2/pt
Priority to CN200980155785.7A priority patent/CN102301006B/zh
Priority to US13/141,787 priority patent/US9624548B2/en
Priority to ES09805934T priority patent/ES2725150T3/es
Priority to AU2009332712A priority patent/AU2009332712B2/en
Priority to MX2011006773A priority patent/MX343251B/es
Priority to CA2747760A priority patent/CA2747760C/en
Priority to NZ593392A priority patent/NZ593392A/xx
Priority to IL213510A priority patent/IL213510A/en
Priority to ZA2011/05184A priority patent/ZA201105184B/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • Pulmonology (AREA)
  • Urology & Nephrology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
GBGB0823445.2A 2008-12-23 2008-12-23 Biomarker Ceased GB0823445D0 (en)

Priority Applications (15)

Application Number Priority Date Filing Date Title
GBGB0823445.2A GB0823445D0 (en) 2008-12-23 2008-12-23 Biomarker
NZ593392A NZ593392A (en) 2008-12-23 2009-12-21 Biomarker for detecting bladder cancer
CN200980155785.7A CN102301006B (zh) 2008-12-23 2009-12-21 生物标志
ES09805934T ES2725150T3 (es) 2008-12-23 2009-12-21 Biomarcador
EP09805934.8A EP2382327B1 (en) 2008-12-23 2009-12-21 Biomarker
RU2011130795/10A RU2573925C2 (ru) 2008-12-23 2009-12-21 Биомаркер
BRPI0923525-6A BRPI0923525A2 (pt) 2008-12-23 2009-12-21 biomarcador específico para câncer de bexiga, seus usos, anticorpo ou fragmento do mesmo, composições, vacina, kit, e métodos para diagnosticar, formar imagem e monitorar a progressão e eficácia de um tratamento do câncer de bexiga em um paciente
JP2011541583A JP5947040B2 (ja) 2008-12-23 2009-12-21 バイオマーカー
US13/141,787 US9624548B2 (en) 2008-12-23 2009-12-21 Methods for diagnosing cancer
PCT/GB2009/002926 WO2010073001A1 (en) 2008-12-23 2009-12-21 Biomarker
AU2009332712A AU2009332712B2 (en) 2008-12-23 2009-12-21 Biomarker
MX2011006773A MX343251B (es) 2008-12-23 2009-12-21 Biomarcador.
CA2747760A CA2747760C (en) 2008-12-23 2009-12-21 Engrailed-2 (en2) biomarker for bladder cancer
IL213510A IL213510A (en) 2008-12-23 2011-06-13 Biomarker
ZA2011/05184A ZA201105184B (en) 2008-12-23 2011-07-14 Biomarker

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0823445.2A GB0823445D0 (en) 2008-12-23 2008-12-23 Biomarker

Publications (1)

Publication Number Publication Date
GB0823445D0 true GB0823445D0 (en) 2009-01-28

Family

ID=40344114

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0823445.2A Ceased GB0823445D0 (en) 2008-12-23 2008-12-23 Biomarker

Country Status (15)

Country Link
US (1) US9624548B2 (enExample)
EP (1) EP2382327B1 (enExample)
JP (1) JP5947040B2 (enExample)
CN (1) CN102301006B (enExample)
AU (1) AU2009332712B2 (enExample)
BR (1) BRPI0923525A2 (enExample)
CA (1) CA2747760C (enExample)
ES (1) ES2725150T3 (enExample)
GB (1) GB0823445D0 (enExample)
IL (1) IL213510A (enExample)
MX (1) MX343251B (enExample)
NZ (1) NZ593392A (enExample)
RU (1) RU2573925C2 (enExample)
WO (1) WO2010073001A1 (enExample)
ZA (1) ZA201105184B (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2472856B (en) 2009-08-21 2012-07-11 Cantargia Ab IL1-RAP modulators and uses thereof
JP5940093B2 (ja) 2011-01-19 2016-06-29 カンタージア アクチエボラーグ 抗ｉｌ−１ｒａｐ抗体及びヒトを処置するためのそれらの使用
EP3479102A1 (en) * 2016-07-04 2019-05-08 CellTool GmbH Device and method for the determination of transfection
KR101777085B1 (ko) * 2017-02-23 2017-09-11 주식회사 성균바이오텍 En2 단백질의 면역원성 단편 펩타이드 또는 이를 특이적으로 인식하는 항체 조성물
KR101923199B1 (ko) 2018-04-25 2018-11-28 주식회사 무진메디 펩스타틴 a를 함유하는 소변 내 en2 진단용 조성물
US20220389514A1 (en) 2019-10-02 2022-12-08 Kyushu University, National University Corporation Biomarker, method, kit and array for predicting therapeutic effects of bcg intravesical infusion therapy in treating bladder cancer

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2469089A1 (en) * 2003-07-08 2005-01-08 Institut De Recherches Cliniques De Montreal En-2 gene, disgnostic and therapeutic uses thereof
US7998695B2 (en) * 2005-02-10 2011-08-16 Oncotherapy Science, Inc. Method of diagnosing bladder cancer
GB0625321D0 (en) * 2006-12-19 2007-01-24 Univ Surrey Cancer biomarker
PL2258871T3 (pl) * 2007-01-19 2014-10-31 Epigenomics Ag Sposoby i kwasy nukleinowe do analizy zaburzeń proliferacyjnych komórki
US20110003292A1 (en) 2007-12-11 2011-01-06 Dimo Dietrich Methods and nucleic acids for analyses of cell proliferative disorders

Also Published As

Publication number Publication date
WO2010073001A1 (en) 2010-07-01
EP2382327A1 (en) 2011-11-02
CN102301006B (zh) 2015-07-15
MX343251B (es) 2016-10-31
IL213510A (en) 2016-04-21
RU2011130795A (ru) 2013-01-27
EP2382327B1 (en) 2019-02-13
RU2573925C2 (ru) 2016-01-27
NZ593392A (en) 2013-05-31
JP2012513584A (ja) 2012-06-14
MX2011006773A (es) 2011-08-03
ZA201105184B (en) 2012-02-29
BRPI0923525A2 (pt) 2020-08-11
US20120020888A1 (en) 2012-01-26
IL213510A0 (en) 2011-07-31
CA2747760A1 (en) 2010-07-01
ES2725150T3 (es) 2019-09-19
CA2747760C (en) 2020-01-21
US9624548B2 (en) 2017-04-18
JP5947040B2 (ja) 2016-07-06
CN102301006A (zh) 2011-12-28
AU2009332712A1 (en) 2011-07-07
AU2009332712B2 (en) 2015-05-28

Similar Documents

Publication Publication Date Title
EP2373999A4 (en) NEW BIOMARKERS
EP2280616A4 (en) BODY FOR BABY
GB0904835D0 (en) Trailersafe
EP2285758A4 (en) DISPOSABLE PACKAGING FOR FERTILIZER-PESTICIDE
EP2313147A4 (en) crimping
GB0903417D0 (en) Biomarkers
GB0921329D0 (en) Biomarker
GB0818660D0 (en) Biomarkers
EP2233305A4 (en) GRAPHIC PRINTER
ZA201105184B (en) Biomarker
GB0815068D0 (en) Insectical combinations
GB0807214D0 (en) Biomarkers
GB0915736D0 (en) Biomarkers
GB0821912D0 (en) Biomarkers
GB0818658D0 (en) Biomarkers
IL217333A0 (en) Biomarker
GB0903391D0 (en) Biomarkers
GB0912175D0 (en) Biomarker
GB0922236D0 (en) Biomarkers
GB0809105D0 (en) Biomarkers
GB0805081D0 (en) Biomarkers
GB0805084D0 (en) Biomarkers
GB0708064D0 (en) Biomarker
GB0922227D0 (en) Biomarkers
GB0905096D0 (en) Biomarkers

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)